| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
254,036,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$22.93 - $22.93 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Gilligan Claire A |
Senior V.P., Quality |
• – – |
2013-01-22 |
4 |
S |
$13.50 |
$12,811 |
D/D |
(949) |
67,427 |
|
- |
|
| Boissonneault Roger M |
CEO & President |
• • – |
2013-01-22 |
4 |
S |
$13.50 |
$187,973 |
D/D |
(13,924) |
2,239,751 |
|
- |
|
| Herendeen Paul |
Exec. V.P. and CFO |
• – – |
2013-01-22 |
4 |
S |
$13.50 |
$58,117 |
D/D |
(4,305) |
106,591 |
|
- |
|
| Fuhrmann Rochelle |
Senior V.P., Finance |
• – – |
2013-01-22 |
4 |
S |
$13.50 |
$6,588 |
D/D |
(488) |
44,851 |
|
- |
|
| Halstead Michael |
Senior V.P., Corp. Development |
• – – |
2013-01-22 |
4 |
S |
$13.50 |
$6,588 |
D/D |
(488) |
40,220 |
|
- |
|
| Hara Izumi |
Senior V.P. |
• – – |
2012-12-31 |
4 |
D |
$0.00 |
$0 |
D/D |
(30,859) |
43,026 |
|
- |
|
| Murray Stephen P |
Director |
– • – |
2012-11-28 |
4 |
S |
$11.41 |
$74,069,361 |
I/I |
(6,491,618) |
0 |
|
- |
|
| Murray Stephen P |
Director |
– • – |
2012-11-20 |
4 |
S |
$11.66 |
$58,300,000 |
I/I |
(5,000,000) |
6,491,618 |
|
- |
|
| Halstead Michael |
Senior V.P., Corp. Development |
• – – |
2012-10-01 |
4 |
S |
$13.55 |
$1,043 |
D/D |
(77) |
40,708 |
|
- |
|
| Gilligan Claire A |
Senior V.P., Quality |
• – – |
2012-10-01 |
4 |
S |
$13.55 |
$3,577 |
D/D |
(264) |
68,376 |
|
- |
|
| Bain Capital (wc) Netherlands B.v |
10% Owner |
– – • |
2012-09-11 |
4 |
S |
$13.10 |
$168,864,882 |
I/I |
(12,890,449) |
11,491,622 |
|
- |
|
| Connaughton John |
Director |
– • • |
2012-09-11 |
4 |
S |
$13.10 |
$168,864,882 |
I/I |
(12,890,449) |
11,491,622 |
|
- |
|
| Abbrecht Todd M |
Director |
– • – |
2012-09-11 |
4 |
S |
$13.10 |
$183,400,000 |
I/I |
(14,000,000) |
11,491,622 |
|
- |
|
| Thomas H Lee Advisors Alternative V Ltd Ldc |
10% Owner |
– – • |
2012-09-11 |
4 |
S |
$13.10 |
$183,400,000 |
I/I |
(14,000,000) |
11,491,622 |
|
- |
|
| Herendeen Paul |
Exec. V.P. and CFO |
• – – |
2012-09-11 |
4 |
S |
$13.10 |
$4,051,044 |
D/D |
(309,240) |
110,896 |
|
- |
|
| Hara Izumi |
Senior V.P. |
• – – |
2012-09-11 |
4 |
S |
$13.10 |
$1,663,608 |
D/D |
(126,993) |
73,885 |
|
- |
|
| Howard Alvin D |
Sr. V.P., Regulatory Affairs |
• – – |
2012-09-11 |
4 |
S |
$13.10 |
$1,934,071 |
D/D |
(147,639) |
89,537 |
|
- |
|
| Ellman Herman |
Senior V.P., Clinical Devel. |
• – – |
2012-09-11 |
4 |
S |
$13.10 |
$307,850 |
D/D |
(23,500) |
170,872 |
|
- |
|
| Murray Stephen P |
Director |
– • – |
2012-09-11 |
4 |
S |
$13.10 |
$183,400,000 |
I/I |
(14,000,000) |
11,491,618 |
|
- |
|
| Jpmp Capital Corp |
10% Owner |
– – • |
2012-09-11 |
4 |
S |
$13.10 |
$376,787,768 |
D/D |
(28,762,425) |
675,209 |
|
- |
|
| J.p. Morgan Partners Global Investors (cayman/sell |
10% Owner |
– – • |
2012-09-11 |
4 |
S |
$13.10 |
$376,787,768 |
D/D |
(28,762,425) |
675,209 |
|
- |
|
| Bain Capital (wc) Netherlands B.v |
10% Owner |
– – • |
2012-09-05 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,109,551) |
24,382,071 |
|
- |
|
| Connaughton John |
Director |
– • • |
2012-09-05 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,109,551) |
24,382,071 |
|
- |
|
| Halstead Michael |
Senior V.P., Corp. Development |
• – – |
2012-07-02 |
4 |
S |
$17.96 |
$6,376 |
D/D |
(355) |
40,785 |
|
- |
|
| Van Zoonen Marinus Johannes |
President, Europe/Intl & Mkt. |
• – – |
2012-04-02 |
4 |
S |
$16.95 |
$11,916 |
D/D |
(703) |
148,240 |
|
- |
|
380 Records found
|
|
Page 5 of 16 |
|
|
